Genalyte Raises $11.8M
socalTECH
MARCH 30, 2012
The round came from Redmile Group, Claremont Creek Ventures, as well as earlier investors in the firm. The company said the new funding will go towards commercialization of its platform, which it is targeting at autoimmune and immunoassay applications. said this morning that it has raised $11.8M in a Series B financing round.
Let's personalize your content